SNPMiner Trials (Home Page)
Report for Mutation C19P
Developed by Shray Alag, 2020.
SNP Clinical Trial Gene
There is one clinical trial.
Clinical Trials
1 COVID-19 Phobia and Quality of Life in Patients With Bronchiectasis During Covid-19 Pandemic
In the literature, there are no studies evaluating COVID-19 phobia, quality of life, health anxiety, physical activity level and quality of sleep in patients with bronchiectasis during COVID-19 pandemic. The investigators will evaluate these parameters in patients with bronchiectasis and compare the findings of healthy individuals during COVID-19 pandemic
NCT04487873 Covid19 Bronchiectasis MeSH:Bronchiectasis
HPO:Bronchiectasis
COVID-19 phobia was evaluated with COVID-19 Phobia Scale (C19P-S) and total score ranges from 20-100. --- C19P ---
Primary Outcomes
Description: COVID-19 phobia was evaluated with COVID-19 Phobia Scale (C19P-S) and total score ranges from 20-100. Lower scores mean better outcome.
Measure: COVID-19 Phobia Time: 5 minutesDescription: Quality of life was evaluated with Nottingham Health Profile
Measure: Qol Time: 10 minutesSecondary Outcomes
Description: Health anxiety was evaluated with Health Anxiety Inventory
Measure: Health anxiety Time: 10 minutesDescription: Physical activity level was evaluated with International Physical Activity Questionnaire - Short Form (IPAQ-SF)
Measure: Physical activity Time: 5 minutesDescription: Quality of sleep was evaluated with Pittsburgh Sleep Quality Index
Measure: Quality of sleep Time: 10 minutes